The management of hyperthyroidism in children with emphasis on the use of radioactive iodine

Pediatric Endocrinology Reviews

Volumn 1, Issue SUPLL. 2, 2003, Pages 212-222

  Rivkees, Scott A ^a   Sack, J ^b   Laron, Z ^b   Saka, N ^b   Glaser, B ^b   Reiner, C ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Pediatrics ^*

Author keywords

Complications; Hyperthyroidism; Pediatric; Radioactive iodine; Remission

Indexed keywords

ANTITHYROID AGENT; IODINE; IODINE 131; PROPYLTHIOURACIL; QUININE; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE;

ABDOMINAL PAIN; ADOLESCENT; AGRANULOCYTOSIS; ARTHRALGIA; BONE MARROW SUPPRESSION; CANCER RISK; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; EXPERIENCE; FEMALE; FEVER; HEPATITIS; HIGH RISK POPULATION; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; LIVER FAILURE; MALE; MOUTH ULCER; NAUSEA; OUTCOMES RESEARCH; PATIENT MONITORING; RADIATION DOSE; RASH; REMISSION; SIDE EFFECT; SORE THROAT; THYROIDECTOMY;

CHILD; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 2342599885     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (116)

1. Takashima S, Nomura N, Tanaka H, Itoh Y, Miki K, Harada T. Congenital hypothyroidism: assessment with ultrasound. AJNR Am J Neuroradial 1995;16:1117-1123
2. Wilkins L. The Diaganosis and treatment of Endocrine disorders in Children and Adolescence. Charles Thomas, Springfield. 1965 Hypothyroidism 1965:141-150
3. Wilkins L. The Diaganosis and treatment of Endocrine disorders in Children and Adolescence. Charles Thomas, Springfield. 1965 Hypothyroidism 1965:141-150
4. Rivkees SA, Sklar C, Freemark M. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-3776
5. Fisher DA. Graves' disease in children. Curr Ther Endocrinol Metab 1994;5:71-74
6. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998;27:109-126
7. LeFranchi S, Mandel SH. Graves' disease in the neonatal period and childhood. Clinical Text. J.B. Lippincott, Philidelphia 1995;1237-1246
8. Chapman EM. History of the discovery and early use of radioactive iodine. Jama 1983;250:2042-2044
9. Hayek A, Chapman EM, Crawford JD. Long term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 1970;283:949-953
10. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 1975;292:167-171
11. Crile G, Schumacher OP. Radioactive iodine treatment of Graves' disease. Results in 32 children under 16 years of age. Am J Dis Child 1965;110:501-504
12. Robertson, CA G. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med 1976;17
13. Williams ED. Biological effects of radiation on the thyroid. In: Braverman LE, Utiger RD, eds. The Thyroid. Vol. 6. Phildelphia: J.B. Lippincott Co., 1986:421-436
14. Goolden AWG, Davey JB. The ablation of normal thyroid tissue with iodine-131. Br J Radiol. 1963;36:340-345
15. Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309:937-941
16. Levy WM, Schumacher OP, Gupta M. Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med 1988;55:373-382
17. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997;7:247-251
18. Graham GD, Barman KD. Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med 1986;105:900-905.
19. Quimby EM, Feitelberg S, Gross W. Radioactive Nuclides in Medicine and Biology: Lea and Febigir, 1970:129
20. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 1995;25:186-193
21. Vitti P, Martino E, Aghini-Lombardi, et al. Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab 1994;79:600-603
22. Ueda D. Normal volume of the thyroid gland in children. J Clin Ultrasound 1990;18:455-462
23. Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA. Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab 2001;86:1865-1867
24. Becker DV, Hurly. Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med 1971;1:442-460
25. Refetoff S, N D-M, AM E, De Groot LJ. Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy. J Nucl Med Allied Sci 1977;21:23-29
26. Ross DS, Daniels GH, De Stefano P, Maloof F, Ridgway EC. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab 1983;57:250-253
27. Aizawa Y, Yoshida K, Kaise H, Fukazawa H. The development of transient hypothyroidism after iodine-131I treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf) 1997;16:1-5
28. Rappaport R, Caplan, De Groot LJ. Low-dose sodium iodine I 131 therapy in Graves disease. Jama 1973;224:1610-1613
29. Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of opthalmopathy. Am J of Med 1989;87:70-73
30. Goolden AW, Stewart JS. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1986;24:217-222
31. McCullagh, GL J, Rodriguez-Antunez. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease. Oh State Med J 1976;72:538-540
32. Dobyns BM. Radiation effects on the thyroid. Effects vary with dosage and sensitivity of the gland to radiation. RI Med J 1975;58:94-7, 122-5
33. Safa AM. Treatment of hyperthyroidism with a large initial dose of sodium iodine 113I. Arch Intern Med 1975;135:673-675
34. Chiovato L, Fiore E, Vitti P, et al. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 1998;83:40-46
35. Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N. Changes in thyroid volumes in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of throid-stimulatinf antibody and treatment outcome. J Clin Endocrinol Metab 1996;81:3257-3260
36. Hancock LD, Tuttle RM, LeMar H, Baumen J, Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf) 1997;47:425-430
37. Allahabadia A, Daykin J, Sheppard MC, Cough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 2001;86:3611-3617
38. Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995;5:243-247
39. Yoshida, Aizawa, Kaise, et al. Relationship between thryoid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine fro Graves' disease: retrospective clinical survey. J Clin Endocrinol Invest 1996;19:682-686
40. Imseis, L V, JD M, Bush, NR V, Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83:685-687
41. Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 1985;60:1019-1024
42. Freitas, DP S, MD G, Sisson JC. Iodine 131-I: optimal therapy for thyroidism in children and adolescents? J Nucl Med 1979;20:847-850
43. Starr P, Jaffe HL, LJ O. Late results of 131I treatment of hyperthyroidism in 73 children and adolescents. J Nucl Med 1964;5:81-89
44. Starr, H J, LJ O. Later results of 131-I treatment of hyperthyroidism in 73 children and adolescence: 1967 follow-up. J Nucl Med 1969;10:586-590
45. Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D. Treatment of hyperthyroidism in children: analysis of fourty-five patients. N Engl J Med 1965;272:217-222
46. Moll, BR P. Pediatric Graves' Disease: therapeutic options and experience with radioiodine at the University of Mississippi Medical center. South Med J 1997;90
47. Sheline GE, McCormack KR, Galante M. Thyroid nodules occurring late after treatment of thryotoxicosis with radioiodine. J Clin Endocrinol Metab 1962;22:8-17
48. Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 2003;111:745-749
49. Goolden, KC K, ML F, AJ M. Oedema of the neck after ablation of the thyroid with radioactive iodine. Br J Radiol 1986;59:583-586
50. Craswell. Vocal cord paresis following radioactive iodine therapy. Br J Clin Pract 1972;26:571-572
51. Dermott M, Kidd G, Dodson LE J, FD H. Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 1983;75:353-359
52. De Groot LJ, CA G, Pinchera A, et al. Therapeutic controversies. Retro-orbital radiation and radioactive iodide alblation of the thyroid may be good for Graves' opthalmopathy. J Clin Endocrinol Metab 1995;80:339-340
53. Tallstedt L, Lundell G. Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective. Thyroid 1997;7:241-245
54. Saxena KM CJ, Talbot NB. Childhood thryotoxicosis: a long term perspective. British Medical Journal 1964;2:1153-1158
55. Lafranchi S. Thyroiditis and acquired hypothyroidism. Pediatr Ann 1992;21:29, 32-39
56. Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolscence. Journal of Pediatrics 1977;91:313-320
57. Miccoli P, Vitti P, Rago T, et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 1996;120:1020-4; discussion 1024-5
58. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-78
59. Duffy, PJ F. Cancer of the thyroid in children: a report of twenty-eight cases. J Clin Endocrinol Metab 1950;10:1296-1308
60. Boice JD J. Radiation and thyroid cancer-what more can be learned? ACTA Oncol 1998;34:321-324
61. Tucker, Jones PH, Boice JD, Jr., et al. Therapeutic radiation at a young age is linked to secondary thyroid caner. Late Effects Study Group. Caner Res 1991;51:2885-2888
62. Dobyns BM, Sheline CE, Workman JB, Tompkins EA, McConahey WM, Seeker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 1974;38:976-998
63. Ron E, Lubin J, RE S, et al. Thyroid Cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-277
64. Farbota LM, Calandra DB, Lawrence AM, Paloyan E. Thyroid carcinoma in Graves' disease. Surgery 1985;98:1148-1153
65. Karlan, WF P, WH S. Carcinoma of the thyroid following treatment of hyperthyroidism with radioactive iodine. Calif Med J. 1964;101:196-201.
66. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 1992;131:98-111
67. German, JS R. Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma. Ann Intern Med 1978;89:85-90
68. Tooney RE, Stabin MG. Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99-1064, 1999., Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium, Gatlinburg, TN, 1996
69. Tooney RE, Stabin MG, Watson EE. The AAPM/RSNA physics tutorial for residents: Internal radiation dosimetry: principles and applications. Radiographics 2000;20:533-546
70. Committee on Health Effects of Exposure to Low Levels of Ionizing Radiations (Beir VII) NRC. Health Effects of Exposure to Low Levels of Ionizing Radiations: Time for Reassessment? Washington, D.C.: National Academy of Science, 1998
71. Hendee WR. Estimation of radiation risks. BEIR V and its significance for medicine. Jama 1992;268:620-624
72. Committee on the Biological Effects of Ionizing Radiation (BEIR V) NRC. Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V. Washington D.C.: National Academy Press, 1990
73. Ron E, Doody, Seeker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. Jama 1998;280:347-355
74. Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med 1976;17:460-464
75. Schull WJ, Otake M, Heel JV. Genetic effects of the atomic bombs:a reappraisal. Science 1981;213:1220-1227
76. Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD. Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 1981;135:112-117
77. Chins T, Warden MJ, Fefferman RA. Thyroid surgery in children and teenagers. Arch otolaryngol 1977;103:544-546
78. Altman RP. Total thyroidectomy for the treatment of Graves' disease in children. J of ped surg 1973;8:295-300
79. Perzik SL. Total thyroidectomy in Graves' disease in children. J Pediatr Surg 1976;11:191-194
80. Rudbers, Johansson H, Akerstrom G, Tuvemo, Karlsson FA. Graves' disease in children and adolescents. Late results of surgical treatment. Eur J Endocrinol 1996;134:710-715
81. Foster R, Jr. Morbidity and mortality after thyroidectomy. Surg Gynecol Obstet 1978;146:423-429
82. Witte J, Goretzki PE, Dotzenrath C, et al. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 2000;24:1303-1311
83. Spinelli C, Bertocchini A, Lima M, Miccoli P. Graves-Basedow's disease in children and adolescents: total vs subtotal thyroidectomy. Pediatr Med Chir 2002;24:383-386
84. Argov S, Duek D. The vanishing surgical treatment of Graves' disease: review of current literature and experience with 50 patients. Curr Surg 1982;39:158-162
85. Osler. Graves Disease. In the practice of medicine. D. Appleton, New York 1935;900-907
86. Talbot NB SE, McArthur JW, Crawford JD. In Functional Endocrinology: From Birth to Adolescence. Harvard University Press, Cambridge 1952;1-51
87. Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 1998;27:225-247
88. Cooper DS. Which Anti-thyroid drug? Am J Med 1986;80:1165-1168
89. Dallas, Foley. Hyperthyroidism. Pediatric Endocrinology. Marcel Dekker, Inc. New York 1996;401-414
90. Mashio Y, Beniko M, Ikota A, Mizumoto H, Kunita H. Treatment of hyperthyroidsim with a single daily dose of methimazole. Acta Endocrinol Suppl (Copenh) 1988;119:139-144
91. Mashio Y, Beniko M, Matsuda A, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole: a prospective long-term follow-up study. Endocr J 1997;44:553-558
92. Shiroozu, Okamura, Ikwnouw, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole. J Clin Endocrinol Metab 1986;63:125-128
93. Greer, Meihoff, Studer. Treatment of hyperthyroidism with a single daily dose of propylthiouracil. N Engl J Med 1965;272:888-891
94. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest 1996;26:59-63
95. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000;343:185-189
96. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy, twenty-five percent remission every two years. J Clin Endocrinol Metab 1987;64:1241-1245
97. Amrhein, Kenny, Ross. Granulocytopenia, lupus-like syndrome, and other complications of propythiouracil therapy. Journal of Pediatrics 1970;76:54-63
98. Tajiri J, Noguchi S, Murakami N. Usefullnes of granulocyte count measurement for hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia. Thyroid 1997;7:575-578
99. Magner JA, Snyder DK. Methimazole-induced agranulocutosis treated with recombinant human granulocute colony-stimulating factor (G-CSF). Thyroid 1994;4:295-296
100. Hanson JS. Propylthiouracil and Hepatitis. Two cases and a review of the literature. Arch Intern Med 1984;144:994-996
101. Bartalena L, Bogazzi F, Martina E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Saf 1996;15:53-63
102. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 2000;85:3678-3682
103. Crawford JD. Hyperthyoidism in children. A reevaluation of treatment. Am J Dis Child 1981;135:109-110
104. Hung W, Wilkins L, Blizzard RM. Medical therapy of thyrotoxicosis in children. Pediatrics 1962;30:17-26
105. Vaidya, Bongiovanni, Parks, Tenore A, Kirkland JL. Twenty-two years experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974;54:565-570
106. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: Comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755-60
107. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997;7:369-375
108. Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K, Cho BY. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications. J Clin Endocrinol Metab 1997;82:1953-1959
109. Davies T, Roti E, Braverman LE, De Groot LJ. Thyroid conterversy- stimulating antibodies. J Clin Endocrinol Metab 1998;83:3777-3785
110. Rapoport B, Greenspan FS, Filetti, Pepitone. Clinical experience with a human thyroid cell bioassay for thyroid-stimulatin immunoglobulin. J Clin Endocrinol Metab 1984;58:332-338
111. Wilson R, McKilop JH, Henderson N, Pearson DW, Thomson JA. The ability of the serum throtrophin receptr antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf) 1986;25
112. Bouma DJ, Kammer H, Greer MA. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease. J Clin Endocrinol Metab 1982;55:1138-1142
113. Greer MA, Kammer H, Bouma DJ. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves' disease. N Engl J Med 1977;297:173-176
114. Bing RF. Early remission in thyrotoxicosis produced by short coursed of treatment. Acta Endocrinol Suppl (Copenh) 1982;100:221-223
115. Allannic H, Fauchet R, Orgiazzi J, et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficavy of treatment duration. J Clin Endocrinol Metab 1990;70:675-679
116. Garcia-Mayor, Paromo, Cano L, Mendez P, Galofre, Andrade. Antithyroid drug and Graves hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. J Clin Endocrinol Invest 1992;15:815-820